FDA inspection
Mayor Pharmaceutical Laboratories, Inc: FDA inspection ending Nov 8, 1999
FDA inspection 3151 · Tempe, AZ
Key facts
| Inspection ID | 3151 |
|---|---|
| Firm | Mayor Pharmaceutical Laboratories, Inc |
| FEI number | 2024825 |
| Address | 3015 S 48th St Ste 101 |
| City | Tempe |
| State | AZ |
| ZIP | 85282-3137 |
| Fiscal year | 2000 |
| Inspection end date | Nov 8, 1999 |
| Project area | Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data